Room-Temperature Kit Synthesis of 18F-FDS from 18F-FDG
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for manufacturing 2-deoxy-2-[18F]fluoro-D-sorbitol (18F-FDS) require dedicated infrastructure and personnel, limiting its on-demand availability and clinical impact.
Innovation Solution
A self-contained kit-based method using a solid-supported borohydride source, such as triethylammonium methylpolystyrene borohydride, to convert commercially available 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) into 18F-FDS at room temperature, allowing for rapid synthesis and purification without specialized equipment or extensive training.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional methods are used to manufacture 18F-FDS, then manufacturing precision and reliability are maintained, but device complexity and infrastructure requirements increase significantly
Solution Approach 1:
The conventional complex manufacturing process is segmented into a simple two-step protocol: (1) mixing 18F-FDG with solid-supported borohydride reagent in a vial, and (2) purification via cartridge. This segmentation transforms a complex infrastructure-dependent process into a simple kit-based procedure that can be performed in any radiopharmacy without specialized equipment.
Solution Approach 2:
A solid-supported borohydride reagent (intermediary) is introduced to mediate the reduction of 18F-FDG to 18F-FDS. This intermediary reagent, immobilized on solid support, enables the reaction to proceed under mild conditions without requiring specialized infrastructure, while maintaining high radiochemical yield and purity.
2Productivity
If conventional infrastructure is used, then manufacturing precision is maintained, but productivity and on-demand availability decrease
Solution Approach 1:
The borohydride reagent is pre-immobilized on solid support and prepared in advance as a stable kit component. This preliminary action allows the actual synthesis to be performed rapidly on-demand by simply mixing the pre-prepared reagent with 18F-FDG, eliminating the need for complex infrastructure and enabling quick production within minutes.
Solution Approach 2:
The reaction conditions are changed from conventional high-temperature or extended-time protocols to a room-temperature, short-duration process (completed in minutes). This parameter change, enabled by the solid-supported reagent, dramatically increases productivity and on-demand availability without sacrificing product quality.
3Ease of operation
If simple kit-based method is used, then ease of operation is improved, but manufacturing precision may worsen
Solution Approach 1:
The kit uses disposable single-use components (vials, cartridges, pre-prepared reagent) that are designed for one-time use. This approach maintains ease of operation while ensuring consistent manufacturing precision by eliminating cross-contamination and variability associated with reusable equipment and complex procedures.
Solution Approach 2:
The borohydride reagent is formulated as a composite material combining the active reducing agent with a solid support matrix. This composite structure maintains the chemical reactivity needed for high manufacturing precision while enabling simple handling and operation that does not require specialized infrastructure or extensive training.
4Adaptability or versatility
If dedicated infrastructure is required, then reliability is improved, but adaptability and versatility decrease
Solution Approach 1:
The kit-based method creates a universal platform that can be implemented in any radiopharmacy regardless of infrastructure. The same simple protocol using solid-supported borohydride can produce 18F-FDS reliably in diverse settings, from well-equipped centers to resource-limited locations, thereby achieving both adaptability and reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables on-demand production of 18F-FDS in less than 10 minutes, achieving greater than 90% radiochemical purity and 60% yield, facilitating its use in routine clinical PET imaging for infectious conditions.
Implementation Method 1
contacting the aliquot of 18F-FDG with a solid-supported borohydride source to form 18F-FDS
Implementation Method 2
contacting the 18F-FDS formed in step (b) with one or more resins selected from the group consisting of a cation exchanger, anion exchanger
Implementation Method 3
purifying the 18F-FDS by contacting the 18F-FDS formed in step (b) with one or more resins
Data Source
AI summary
A self-contained kit and method for the on-demand synthesis of 2-deoxy-2-[18F]fluoro-D-sorbitol (18F-FDS) from commercially available 2-deoxy-2-[F18]fluoroglucose (18F-FDG) is disclosed.